keynote 671: perioperative pembrolizumab for nsclc - onctalk lung 2023
Published 6 months ago • 93 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:57
keynote 091: adjuvant pembrolizumab - onctalk lung 2023
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
1:24
checkmate 77t: perioperative nivolumab in nsclc - onctalk lung 2023
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
1:44
extended interval dosing for pembrolizumab - lung cancer onctalk 2022
-
2:30
advances in oligometastatic disease - onctalk lung 2023
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
3:14
stereotactic body radiotherapy (sbrt) for oligoprogressive nsclc - onctalk lung 2023
-
2:02
progression on pembrolizumab: patient without actionable mutations & low pd-l1 - lung cancer onctalk
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
1:59:57
grace - global resource for advancing cancer education live stream
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
4:29
studies in chemoimmunotherapy - lung cancer onctalk 2022
-
2:23
q&a: what does monitoring look like after adjuvant chemotherapy? - onctalk lung 2023
-
3:26
q&a: what does lung cancer surgical recovery look like? - onctalk lung 2023
-
2:57
lobar versus sublobar resection in nsclc - onctalk lung 2023
-
1:33
q&a: how can we learn from unsuccessful studies? - onctalk lung 2023
-
2:11
treating side effects from neoadjuvant chemoimmunotherapy - lung cancer onctalk 2022